Bing‐Mae Chen

1.4k total citations · 1 hit paper
25 papers, 1.1k citations indexed

About

Bing‐Mae Chen is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Bing‐Mae Chen has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Immunology. Recurrent topics in Bing‐Mae Chen's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Glycosylation and Glycoproteins Research (5 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Bing‐Mae Chen is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Glycosylation and Glycoproteins Research (5 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Bing‐Mae Chen collaborates with scholars based in Taiwan, Israel and United States. Bing‐Mae Chen's co-authors include Steve R. Roffler, Tian-Lu Cheng, Tian‐Lu Cheng, Ji‐Wang Chern, André Lieber, Pei‐Chun Wu, Mi‐Hua Tao, Lung‐Sen Kao, Ming‐Fang Wu and Yi‐Chen Lin and has published in prestigious journals such as ACS Nano, The Journal of Immunology and PLoS ONE.

In The Last Decade

Bing‐Mae Chen

25 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies

2021 378 citations Bing‐Mae Chen, Tian-Lu Cheng et al. ACS Nano profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bing‐Mae Chen Taiwan	15	510	270	248	183	182	25	1.1k
Andrey S. Dobroff United States	21	761 1.5×	270 1.0×	105 0.4×	134 0.7×	236 1.3×	35	1.2k
Colin F. Greineder United States	24	522 1.0×	279 1.0×	373 1.5×	178 1.0×	154 0.8×	66	1.5k
Bing-Mae Chen Taiwan	16	516 1.0×	233 0.9×	440 1.8×	247 1.3×	156 0.9×	20	1.1k
Michael Lykke Hvam Denmark	10	968 1.9×	110 0.4×	194 0.8×	141 0.8×	123 0.7×	12	1.3k
Anna Moshnikova United States	22	996 2.0×	233 0.9×	258 1.0×	138 0.8×	184 1.0×	45	1.7k
Sabine Barnert Germany	21	616 1.2×	150 0.6×	267 1.1×	163 0.9×	95 0.5×	27	1.3k
Akshay Jain United States	16	503 1.0×	143 0.5×	270 1.1×	71 0.4×	152 0.8×	21	993
Dimitris Stellas Greece	21	804 1.6×	310 1.1×	109 0.4×	133 0.7×	240 1.3×	50	1.5k
Ladan Parhamifar Denmark	20	612 1.2×	146 0.5×	221 0.9×	122 0.7×	140 0.8×	31	1.0k

Countries citing papers authored by Bing‐Mae Chen

Since Specialization

Citations

This map shows the geographic impact of Bing‐Mae Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing‐Mae Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing‐Mae Chen more than expected).

Fields of papers citing papers by Bing‐Mae Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing‐Mae Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing‐Mae Chen. The network helps show where Bing‐Mae Chen may publish in the future.

Co-authorship network of co-authors of Bing‐Mae Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Bing‐Mae Chen. A scholar is included among the top collaborators of Bing‐Mae Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing‐Mae Chen. Bing‐Mae Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Lin, Hsuan-Pei, Bing‐Mae Chen, Shih‐Hung Yang, et al.. (2024). Engineering stable and non-immunogenic immunoenzymes for cancer therapy via in situ generated prodrugs. Journal of Controlled Release. 369. 179–198. 1 indexed citations

2.

Chen, Wei-An, et al.. (2023). Antibodies against Poly(ethylene glycol) Activate Innate Immune Cells and Induce Hypersensitivity Reactions to PEGylated Nanomedicines. ACS Nano. 17(6). 5757–5772. 52 indexed citations

3.

Lin, Yi‐Chen, et al.. (2023). Accelerated clearance by antibodies against methoxy PEG depends on pegylation architecture. Journal of Controlled Release. 354. 354–367. 20 indexed citations

4.

Bavli, Yaelle, Bing‐Mae Chen, Alon Y. Hershko, et al.. (2023). Anti-PEG antibodies before and after a first dose of Comirnaty® (mRNA-LNP-based SARS-CoV-2 vaccine). Journal of Controlled Release. 354. 316–322. 53 indexed citations

5.

Chen, Bing‐Mae, Tian-Lu Cheng, & Steve R. Roffler. (2021). Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies. ACS Nano. 15(9). 14022–14048. 378 indexed citations breakdown →

6.

Sylvestre, Meilyn, Shixian Lv, David J. Peeler, et al.. (2021). Replacement of L-amino acid peptides with D-amino acid peptides mitigates anti-PEG antibody generation against polymer-peptide conjugates in mice. Journal of Controlled Release. 331. 142–153. 30 indexed citations

7.

Gao, Shijay, Pierre‐Alain Burnouf, Bing‐Mae Chen, et al.. (2021). Entropy-driven binding of gut bacterial β-glucuronidase inhibitors ameliorates irinotecan-induced toxicity. Communications Biology. 4(1). 280–280. 30 indexed citations

8.

Chen, Bing‐Mae, et al.. (2021). Impact of anti-PEG antibody affinity on accelerated blood clearance of pegylated epoetin beta in mice. Biomedicine & Pharmacotherapy. 146. 112502–112502. 19 indexed citations

9.

Bavli, Yaelle, Bing‐Mae Chen, Steve R. Roffler, et al.. (2020). PEGylated Liposomal Methyl Prednisolone Succinate does not Induce Infusion Reactions in Patients: A Correlation Between in Vitro Immunological and in Vivo Clinical Studies. Molecules. 25(3). 558–558. 7 indexed citations

10.

Chen, Bing‐Mae, Wen-Wei Lin, Yi‐Wen Chiu, et al.. (2019). Both IgM and IgG Antibodies against Polyethylene Glycol Can Alter the Biological Activity of Methoxy Polyethylene Glycol-Epoetin Beta in Mice. Pharmaceutics. 12(1). 15–15. 23 indexed citations

11.

Huang, Ming‐Hsi, Yu‐Wen E. Chang, I‐Hua Chen, et al.. (2016). Chimeric peptide containing both B and T cells epitope of tumor-associated antigen L6 enhances anti-tumor effects in HLA-A2 transgenic mice. Cancer Letters. 377(2). 126–133. 12 indexed citations

12.

Lin, Hsuan-Pei, et al.. (2015). Effect of Cellular Location of Human Carboxylesterase 2 on CPT-11 Hydrolysis and Anticancer Activity. PLoS ONE. 10(10). e0141088–e0141088. 14 indexed citations

13.

Chuang, Kuo‐Hsiang, Yuan-Chin Hsieh, Chih-Hung Chuang, et al.. (2014). High-Throughput Sorting of the Highest Producing Cell via a Transiently Protein-Anchored System. PLoS ONE. 9(7). e102569–e102569. 8 indexed citations

14.

Chen, Bing‐Mae, et al.. (2013). The B7-1 Cytoplasmic Tail Enhances Intracellular Transport and Mammalian Cell Surface Display of Chimeric Proteins in the Absence of a Linear ER Export Motif. PLoS ONE. 8(9). e75084–e75084. 9 indexed citations

15.

Chen, Bing‐Mae, Pei‐Chun Wu, Tian‐Lu Cheng, et al.. (2010). Cutting Edge: Mechanical Forces Acting on T Cells Immobilized via the TCR Complex Can Trigger TCR Signaling. The Journal of Immunology. 184(11). 5959–5963. 170 indexed citations

16.

Tzou, Shey-Cherng, Steve R. Roffler, Kuo‐Hsiang Chuang, et al.. (2009). Micro-PET Imaging of β-Glucuronidase Activity by the Hydrophobic Conversion of a Glucuronide Probe. Radiology. 252(3). 754–762. 15 indexed citations

17.

Tsai, Nu‐Man, et al.. (2003). Anti-tumor immunoglobulin M increases lung metastasis in an experimental model of malignant melanoma. Clinical & Experimental Metastasis. 20(2). 103–109. 4 indexed citations

18.

Cheng, Tian‐Lu, et al.. (1997). Poly(ethylene glycol) modification of β-glucuronidase-antibody conjugates for solid-tumor therapy by targeted activation of glucuronide prodrugs. Cancer Immunology Immunotherapy. 44(6). 305–315. 44 indexed citations

19.

Chen, Bing‐Mae, et al.. (1997). Cure of malignant ascites and generation of protective immunity by monoclonal antibody–targeted activation of a glucuronide prodrug in rats. International Journal of Cancer. 73(3). 392–402. 25 indexed citations

20.

Chen, Bing‐Mae, et al.. (1997). Cure of malignant ascites and generation of protective immunity by monoclonal antibody–targeted activation of a glucuronide prodrug in rats. International Journal of Cancer. 73(3). 392–402. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact